Cargando…

Real-world digital implementation of the Psychosis Polyrisk Score (PPS): A pilot feasibility study

BACKGROUND: The Psychosis Polyrisk Score (PPS) is a potential biomarker integrating non-purely genetic risk/protective factors for psychosis that may improve identification of individuals at risk and prediction of their outcomes at the individual subject level. Biomarkers that are easy to administer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliver, Dominic, Spada, Giulia, Englund, Amir, Chesney, Edward, Radua, Joaquim, Reichenberg, Abraham, Uher, Rudolf, McGuire, Philip, Fusar-Poli, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science Publisher B. V 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774585/ https://www.ncbi.nlm.nih.gov/pubmed/32340785 http://dx.doi.org/10.1016/j.schres.2020.04.015

Ejemplares similares

Psychosis Polyrisk Score (PPS) for the Detection of Individuals At-Risk and the Prediction of Their Outcomes
por: Oliver, Dominic, et al.
Publicado: (2019)

M136. PSYCHOSIS POLYRISK SCORE (PPS): IMPROVING DETECTION OF INDIVIDUALS AT-RISK AND PREDICTION OF CLINICAL OUTCOMES
por: Oliver, Dominic, et al.
Publicado: (2020)

Efficacy and Acceptability of Interventions for Attenuated Positive Psychotic Symptoms in Individuals at Clinical High Risk of Psychosis: A Network Meta-Analysis
por: Davies, Cathy, et al.
Publicado: (2018)

T97. REAL WORLD IMPLEMENTATION OF A TRANSDIAGNOSTIC RISK CALCULATOR FOR THE AUTOMATIC DETECTION OF INDIVIDUALS AT RISK OF PSYCHOSIS IN CLINICAL ROUTINE
por: Oliver, Dominic, et al.
Publicado: (2020)

Real World Implementation of a Transdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk of Psychosis in Clinical Routine: Study Protocol
por: Fusar-Poli, Paolo, et al.
Publicado: (2019)

Prognostic accuracy and clinical utility of psychometric instruments for individuals at clinical high-risk of psychosis: a systematic review and meta-analysis
por: Oliver, Dominic, et al.
Publicado: (2022)

Real-world implementation of precision psychiatry: Transdiagnostic risk calculator for the automatic detection of individuals at-risk of psychosis
por: Oliver, Dominic, et al.
Publicado: (2021)

Cannabidiol (CBD) as a novel treatment in the early phases of psychosis
por: Chesney, Edward, et al.
Publicado: (2021)

E-Clinical High Risk for Psychosis: Viewpoint on Potential of Digital Innovations for Preventive Psychiatry
por: Reilly, Thomas, et al.
Publicado: (2019)

Examining the variability of neurocognitive functioning in individuals at clinical high risk for psychosis: a meta-analysis
por: Catalan, Ana, et al.
Publicado: (2022)

F256. CAN WE REDUCE THE DURATION OF UNTREATED PSYCHOSIS?
por: Oliver, Dominic, et al.
Publicado: (2018)

Neighbourhood deprivation is positively associated with detection of the ultra-high risk (UHR) state for psychosis in South East London
por: Bhavsar, V., et al.
Publicado: (2018)

Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation
por: Schmidt, André, et al.
Publicado: (2017)

Acceptability of cannabidiol in patients with psychosis
por: Chesney, Edward, et al.
Publicado: (2022)

Can We Reduce the Duration of Untreated Psychosis? A Systematic Review and Meta-Analysis of Controlled Interventional Studies
por: Oliver, Dominic, et al.
Publicado: (2018)

Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)
por: Fusar-Poli, Paolo, et al.
Publicado: (2019)

Transition to psychosis in randomized clinical trials of individuals at clinical high risk of psychosis compared to observational cohorts: a systematic review and meta-analysis
por: Salazar de Pablo, Gonzalo, et al.
Publicado: (2021)

Methodological Biases in CBT Trial—Commentary: Modular Cognitive-Behavioral Therapy for Affective Symptoms in Young Individuals at Ultra-High Risk of First Episode of Psychosis: Randomized Controlled Trial
por: Fusar-Poli, Paolo, et al.
Publicado: (2020)

Transdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk and the Prediction of Psychosis: Second Replication in an Independent National Health Service Trust
por: Fusar-Poli, Paolo, et al.
Publicado: (2019)

Comorbid Depressive and Anxiety Disorders in 509 Individuals With an At-Risk Mental State: Impact on Psychopathology and Transition to Psychosis
por: Fusar-Poli, Paolo, et al.
Publicado: (2014)

S126. GOOD OUTCOME IN INDIVIDUALS AT ULTRA-HIGH RISK (UHR) OF DEVELOPING PSYCHOSIS: A DELPHI STUDY
por: Petros, Natalia, et al.
Publicado: (2018)

What Causes the Onset of Psychosis in Individuals at Clinical High Risk? A Meta-analysis of Risk and Protective Factors
por: Oliver, Dominic, et al.
Publicado: (2020)

34.2 IMPROVING THE DETECTION OF INDIVIDUALS AT RISK OF PSYCHOSIS IN SECONDARY MENTAL HEALTH CARE
por: Fusar-poli, Paolo, et al.
Publicado: (2018)

Mapping the implementation and challenges of clinical services for psychosis prevention in England
por: Estradé, Andrés, et al.
Publicado: (2023)

Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios
por: Englund, Amir, et al.
Publicado: (2022)

Transdiagnostic Individualized Clinically Based Risk Calculator for the Detection of Individuals at Risk and the Prediction of Psychosis: Model Refinement Including Nonlinear Effects of Age
por: Fusar-Poli, Paolo, et al.
Publicado: (2019)

Why are psychiatric imaging methods clinically unreliable? Conclusions and practical guidelines for authors, editors and reviewers
por: Borgwardt, Stefan, et al.
Publicado: (2012)

T109. TRAVERSING THE TRANSDIAGNOSTIC GAP BETWEEN DEPRESSION, MANIA AND PSYCHOSIS WITH NATURAL LANGUAGE PROCESSING
por: Patel, Rashmi, et al.
Publicado: (2020)

Real-world long-term outcomes in individuals at clinical risk for psychosis: The case for extending duration of care
por: Fusar-Poli, Paolo, et al.
Publicado: (2020)

Formal thought disorder in people at ultra-high risk of psychosis
por: Demjaha, Arsime, et al.
Publicado: (2017)

Outreach and support in South-London (OASIS) 2001—2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis
por: Fusar-Poli, Paolo, et al.
Publicado: (2020)

Diagnostic Stability of ICD/DSM First Episode Psychosis Diagnoses: Meta-analysis
por: Fusar-Poli, Paolo, et al.
Publicado: (2016)

Transition to Psychosis in Individuals at Clinical High Risk: Meta-analysis
por: Salazar De Pablo, G., et al.
Publicado: (2023)

metaumbrella: the first comprehensive suite to perform data analysis in umbrella reviews with stratification of the evidence
por: Gosling, Corentin J, et al.
Publicado: (2023)

Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol products
por: Chesney, Edward, et al.
Publicado: (2020)

34. IMPROVING THE DETECTION OF INDIVIDUALS AT RISK OF PSYCHOSIS
por: Fusar-poli, Paolo
Publicado: (2018)

Cognitive impairment as a risk factor for psychosis
por: Reichenberg, Abraham
Publicado: (2005)

Early Intervention Services for First Episode of Psychosis in South London and the Maudsley (SLaM): 20 Years of Care and Research for Young People
por: Fusar-Poli, Paolo, et al.
Publicado: (2020)

Psychiatric and neuropsychiatric syndromes and COVID-19 – Authors' reply
por: Rogers, Jonathan P, et al.
Publicado: (2020)

Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic
por: Rogers, Jonathan P, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qa508gk6ub1q2l286t2q45724f